Spectrum of mucocutaneous, ocular and facial features and delineation of novel presentations in 62 classical Ehlers‐Danlos syndrome patients
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Classical Ehlers‐Danlos syndrome (cEDS) is characterized by marked cutaneous involvement, according to the Villefranche nosology and its 2017 revision. However, the diagnostic flow‐chart that prompts molecular testing is still based on experts’ opinion rather than systematic published data. Here we report on 62 molecularly characterized cEDS patients with focus on skin, mucosal, facial, and articular manifestations. The major and minor Villefranche criteria, additional 11 mucocutaneous signs and 15 facial dysmorphic traits were ascertained and feature rates compared by sex and age. In our cohort, we did not observe any mandatory clinical sign. Skin hyperextensibility plus atrophic scars was the most frequent combination, whereas generalized joint hypermobility according to the Beighton score decreased with age. Skin was more commonly hyperextensible on elbows, neck, and knees. The sites more frequently affected by abnormal atrophic scarring were knees, face (especially forehead), pretibial area, and elbows. Facial dysmorphism commonly affected midface/orbital areas with epicanthal folds and infraorbital creases more commonly observed in young patients. Our findings suggest that the combination of ≥1 eye dysmorphism and facial/forehead scars may support the diagnosis in children. Minor acquired traits, such as molluscoid pseudotumors, subcutaneous spheroids, and signs of premature skin aging are equally useful in adults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 2017 international classification of the Ehlers–Danlos syndromes
Malfait, F., Francomano, C., Byers, P., Belmont, J., Berglund, B., Black, J., Bloom, L., Bowen, J. M., Brady, A. F., Burrows, N. P., et al. (2017) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31552 · Cited by 1,936 · cited 13×
“However, alternative diagnoses should be considered in the absence of (a) COL5A1, COL5A2, COL1A1 or COL1A2 mutation(s), such as the classical-like EDS due to tenascin X deficiency, hypermobile EDS (hEDS), hypermobility spectrum disorders, kyphoscoliotic EDS, and vascular EDS.2 Although cEDS is recognized by the lay pe…”
BackgroundInfluentialSelf-citationSteinmann, B., Royce, P. M., & Superti‐Furga, A. (2002) · Connective Tissue and Its Heritable Disorders · doi:10.1002/0471221929.ch9 · Cited by 358
Hakim, A., & Grahame, R. (2003) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2003.tb10455.x · Cited by 312
Ehlers-Danlos syndrome, classical type
Bowen, J. M., Sobey, G. J., Burrows, N. P., Colombi, M., Lavallee, M. E., Malfait, F., & Francomano, C. A. (2017) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31548 · Cited by 184
Self-citationRitelli, M., Dordoni, C., Venturini, M., Chiarelli, N., Quinzani, S., Traversa, M., Zoppi, N., Vascellaro, A., Wischmeijer, A., Manfredini, E., et al. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-58 · Cited by 134 · cited 5×
“The influence of age on JHM became more evident during the reassessment of the BS at the follow-up (approximately 5 years after first examination) in 12 previously reported patients.(5) In 9 of them, a decrease of the BS was demonstrated and in 4 of them the BS was <5 (Table S2).”
BackgroundMethodResultInfluentialSelf-citationColombi, M., Dordoni, C., Chiarelli, N., & Ritelli, M. (2015) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31429 · Cited by 127
Self-citationCastori, M., Dordoni, C., Valiante, M., Sperduti, I., Ritelli, M., Morlino, S., Chiarelli, N., Celletti, C., Venturini, M., Camerota, F., et al. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36805 · Cited by 81 · cited 2×
“Atrophic scars are generally large, hemosiderotic, and papyraceous, thus distinguishing cEDS from hEDS that is characterized by small atrophic scars mainly localized on the knees and by post-surgical atrophic scars that are consequent to orthopedic interventions.(12) Conversely, post-surgical scars due to orthopedic i…”
BackgroundSelf-citationCastori, M., Dordoni, C., Morlino, S., Sperduti, I., Ritelli, M., Valiante, M., Chiarelli, N., Zanca, A., Celletti, C., Venturini, M., et al. (2015) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31425 · Cited by 40
Self-citation
Cited by
Chiarelli, N., Ritelli, M., Zoppi, N., & Colombi, M. (2019) · Genes · doi:10.3390/genes10080609 · Cited by 82
“Additional functional work might help to establish the concrete involvement of these proteins including the αvβ3 integrin in the impaired wound healing, which likely leads to the cutaneous manifestations of cEDS [39,77].”
BackgroundSelf-citationChiarelli, N., Carini, G., Zoppi, N., Ritelli, M., & Colombi, M. (2019) · PLOS ONE · doi:10.1371/journal.pone.0211647 · Cited by 35
Self-citationRitelli, M., Cinquina, V., Venturini, M., Pezzaioli, L., Formenti, A. M., Chiarelli, N., & Colombi, M. (2019) · Genes · doi:10.3390/genes10020135 · Cited by 33
“Atrophic scarring can range in severity; however, most cEDS patients have wide atrophic scars in different body areas that can variably assume a cigarette paper, papyraceous, or hemosiderotic appearance [1,2,5].”
BackgroundSelf-citationSkeletal fragility: an emerging complication of Ehlers–Danlos syndrome
Formenti, A. M., Doga, M., Frara, S., Ritelli, M., Colombi, M., Banfi, G., & Giustina, A. (2019) · Endocrine · doi:10.1007/s12020-018-1822-y · Cited by 17
Self-citationColombi, M., Dordoni, C., Cinquina, V., Venturini, M., & Ritelli, M. (2018) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2017.10.005 · Cited by 16
Self-citation
Metadata
- Authors
- Colombi, M., Dordoni, C., Venturini, M., Ciaccio, C., Morlino, S., Chiarelli, N., Zanca, A., Calzavara‐Pinton, P., Zoppi, N., Castori, M., & Ritelli, M.
- Venue
- Clinical Genetics
- Publisher
- Wiley
- Published
- 2017-09-04
- Volume
- 92
- Issue
- 6
- Pages
- 624-631
- ISSN
- 0009-9163 (ISSN-L)
- 1399-0004
- OpenAlex
- W2613109808
- Cited by
- 34
- References
- 8
- FWCI
- 3.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.